TITLE

Neointimal hyperplasia persists at six months after sirolimus-eluting stent implantation in diabetic porcine

AUTHOR(S)
Qi Zhang; Lin Lu; LiJin Pu; RuiYan Zhang; Jie Shen; ZhengBing Zhu; Jian Hu; ZhenKun Yang; QiuJin Chen; WeiFeng Shen
PUB. DATE
January 2007
SOURCE
Cardiovascular Diabetology;2007, Vol. 6, p16
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Observational clinical studies have shown that patients with diabetes have less favorable results after percutaneous coronary intervention compared with the non-diabetic counterparts, but its mechanism remains unclear. The aim of this study was to examine the changes of neointimal hyperplasia after sirolimus-eluting stent (SES) implantation in a diabetic porcine model, and to evaluate the impact of aortic inflammation on this proliferative process. Methods: Diabetic porcine model was created with an intravenous administration of a single dose of streptozotocin in 15 Chinese Guizhou minipigs (diabetic group); each of them received 2 SES (Firebird, Microport Co, China) implanted into 2 separated major epicardial coronary arteries. Fifteen non-diabetic minipigs with SES implantation served as controls (control group). At 6 months, the degree of neointimal hyperplasia was determined by repeat coronary angiography, intravascular ultrasound (IVUS) and histological examination. Tumor necrosis factor (TNF)-α protein level in the aortic intima was evaluated by Western blotting, and TNF-α, interleukin (IL)- 1β and IL-6 mRNA levels were assayed by reverse transcription and polymerase chain reaction. Results: The distribution of stented vessels, diameter of reference vessels, and post-procedural minimal lumen diameter were comparable between the two groups. At 6-month follow-up, the degree of in-stent restenosis (40.4 ± 24.0% vs. 20.2 ± 17.7%, p < 0.05), late lumen loss (0.33 ± 0.19 mm vs. 0.10 ± 0.09 mm, p < 0.001) by quantitative angiography, percentage of intimal hyperplasia in the stented area (26.7 ± 19.2% vs. 7.3 ± 6.1%, p < 0.001) by IVUS, and neointimal area (1.59 ± 0.76 mm² vs. 0.41 ± 0.18 mm², p < 0.05) by histological examination were significantly exacerbated in the diabetic group than those in the controls. Significant increases in TNF-α protein and TNF-α, IL-1β and IL-6 mRNA levels were observed in aortic intima in the diabetic group. Conclusion: Neointimal hyperplasia persisted at least up to 6 months after SES implantation in diabetic porcine, which may be partly related to an exaggerated inflammatory response within the blood vessel wall. Our results provide theoretical support for potential direct beneficial effects of anti-diabetic and anti-inflammation medications in reducing the risk of restenosis after stenting.
ACCESSION #
28682827

 

Related Articles

  • Cutting balloon-assisted angioplasty of an anastomotic carotid-brachial bypass graft stenosis. Prabhudesai, Vikramaditya; Orme, Richard; Fox, Anthony D. // CardioVascular & Interventional Radiology;Jul/Aug2004, Vol. 27 Issue 4, p394 

    Neointimal hyperplasia leads to anastomotic stenosis in bypass grafts. These stenoses are often resistant to conventional balloon dilatation. We present a case of a carotid-brachial bypass graft stenosis, which was treated by a 5-mm cutting balloon angioplasty with a good angiographic and...

  • EVALUATION OF HYPOGLYCEMIC EFFECT OF COW URINE DISTILLATE IN STREPTOZOTOCIN INDUCED DIABETIC RAT MODEL. M. KADAGI; K. JAYAKUMAR; N. B. SHRIDHAR; H. D. NARAYANASWAMY; M. NARAYANASWAMY; K. P. MANJUNATHA // Journal of Cell & Tissue Research;2012, Vol. 12 Issue 3, p3317 

    The present study was designed to determine the hypoglycemic activity of cow urine distillate in streptozotocin induced diabetic rats. The Wister albino rats were divided into five groups (n=10). Group I served as normal control. Diabetes was induced in group II to V by injecting streptozotocin....

  • hemihyperplasia.  // Taber's Cyclopedic Medical Dictionary (2009);2009, Issue 21, p1039 

    A definition of the term "hemihyperplasia," which refers to the excessive development of one side or one half of the body or of an organ, is presented.

  • Azathioprine.  // Reactions Weekly;6/26/2010, Issue 1307, p15 

    The article presents the case of a 54-year-old man who developed hepatic nodular regenerative hyperplasia while receiving azathioprine for Crohn's disease.

  • Mercaptopurine.  // Reactions Weekly;3/19/2011, Issue 1343, p24 

    The article describes the case of a 56-year-old man who developed nodular regenerative hyperplasia and portal hypertension while receiving treatment with mercaptopurine.

  • Clinical Trial Aims to Save Functioning Beta Cells in Newly Diagnosed Patients.  // Countdown;Winter2000, Vol. 21 Issue 1, p16 

    Reports on the planned clinical trial to test the safety, tolerability and effects of an immunosuppressive agent for the treatment of Type 1 diabetes. Testing of the genetically modified form of a drug known as OKT3; Possibility that treatment may prevent the deterioration in insulin secretory...

  • Immunosuppressants.  // Reactions Weekly;7/6/2013, Issue 1460, p26 

    The article presents a case study of a 55-year-old man with the history of diabetes mellitus and who developed Ochroconis gallopava infection after receiving immunosuppressant therapy with antithymocyte globulin.

  • Focal fibrous hyperplasia: A Case Report. Mathur, Lalit Kumar; Bhalodi, Anand P.; Manohar, Balaji; Bhatia, Aman; Rai, Neema; Mathur, Aditi // International Journal of Dental Clinics;2010, Vol. 2 Issue 4, p56 

    Local reactive focal overgrowths are frequently found in the oral cavities. This case reports describes a case of Focal fibrous hyperplasia which was successfully treated by using surgical excision method.

  • Society of Toxicologic Pathology Position on Assessment of Hyperplastic Lesions in Rodent Carcinogenicity Studies. Boorman, Gary; Dixon, Darlene; Elwell, Michael; Kerlin, Roy; Morton, Daniel; Peters, Terry; Regan, Karen; Sullivan, John // Toxicologic Pathology;Jan/Feb2004, Vol. 32 Issue 1, p124 

    Deals with the role of hyperplastic lesions in the assessment of carcinogenicity. Information on hyperplasia; Details of a lack of regulatory guidelines that discuss the relationship of non-neoplastic proliferative changes to neoplastic processes in rodent carcinogenicity studies; Importance of...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics